HUMAN METAPNEUMOVIRUS TEST

This adverse event was reported 6 times

HUMAN METAPNEUMOVIRUS TEST is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ELOTUZUMAB 3 0.0006
1 OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% 1 0.0001
2 OFLOXACIN OTIC SOLUTION 1 0.0001
3 OFLOXACIN OTIC 1 0.0001
4 OFLOXACIN 1 0.0001
5 CARFILZOMIB 1 0.0000
6 VALACYCLOVIR HYDROCHLORIDE 2 0.0000
7 ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL 1 0.0000
8 LATANOPROST 1 0.0000
9 LORATADINE TABLET 1 0.0000
See all drugs enriched for association with HUMAN METAPNEUMOVIRUS TEST

HUMAN METAPNEUMOVIRUS TEST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SLAMF7-directed Immunostimulatory Antibody [EPC] 3 0.0006
1 Quinolone Antimicrobial [EPC] 1 0.0001
2 BCL-2 Inhibitor [EPC] 1 0.0000
3 Prostaglandin Analog [EPC] 1 0.0000
4 Proteasome Inhibitor [EPC] 1 0.0000
5 Calcium [EPC] 1 0.0000
6 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
7 Thalidomide Analog [EPC] 3 0.0000
8 Endothelin Receptor Antagonist [EPC] 1 0.0000
9 Thiazide Diuretic [EPC] 1 0.0000
See all drug classes enriched for association with HUMAN METAPNEUMOVIRUS TEST